Opening https://www.globenewswire.com/news-release/2023/03/14/2627271/0/en/Allogene-Therapeutics-Announces-Oral-Presentation-of-Phase-1-Data-on-ALLO-316-at-the-American-Association-of-Cancer-Research-AACR-Annual-Meeting.html